🇺🇸 FDA
Patent

US 11091441

Solid state crystalline forms of a selective potassium channel modulator

granted A61PA61P25/08

Quick answer

US patent 11091441 (Solid state crystalline forms of a selective potassium channel modulator) held by Xenon Pharmaceuticals Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61P, A61P25/08